Sangamo Therapeutics Inc (SGMO)
0.5115
+0.03
(+5.44%)
USD |
NASDAQ |
Apr 19, 16:00
0.5143
0.00 (0.00%)
After-Hours: 20:00
Sangamo Therapeutics Market Cap: 91.51M for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 19, 2024 | 91.51M |
| April 18, 2024 | 86.79M |
| April 17, 2024 | 92.32M |
| April 16, 2024 | 96.97M |
| April 15, 2024 | 99.31M |
| April 12, 2024 | 97.22M |
| April 11, 2024 | 97.54M |
| April 10, 2024 | 93.75M |
| April 09, 2024 | 100.62M |
| April 08, 2024 | 101.15M |
| April 05, 2024 | 100.40M |
| April 04, 2024 | 102.82M |
| April 03, 2024 | 109.13M |
| April 02, 2024 | 104.02M |
| April 01, 2024 | 108.70M |
| March 28, 2024 | 119.90M |
| March 27, 2024 | 111.76M |
| March 26, 2024 | 107.95M |
| March 25, 2024 | 114.80M |
| March 22, 2024 | 125.77M |
| March 21, 2024 | 173.59M |
| March 20, 2024 | 146.01M |
| March 19, 2024 | 137.76M |
| March 18, 2024 | 152.25M |
| March 15, 2024 | 139.55M |
| Date | Value |
|---|---|
| March 14, 2024 | 139.55M |
| March 13, 2024 | 140.46M |
| March 12, 2024 | 154.06M |
| March 11, 2024 | 157.87M |
| March 08, 2024 | 162.11M |
| March 07, 2024 | 163.76M |
| March 06, 2024 | 179.91M |
| March 05, 2024 | 183.48M |
| March 04, 2024 | 181.70M |
| March 01, 2024 | 197.73M |
| February 29, 2024 | 206.63M |
| February 28, 2024 | 190.60M |
| February 27, 2024 | 201.29M |
| February 26, 2024 | 199.51M |
| February 23, 2024 | 201.29M |
| February 22, 2024 | 195.95M |
| February 21, 2024 | 219.99M |
| February 20, 2024 | 210.20M |
| February 16, 2024 | 245.82M |
| February 15, 2024 | 187.04M |
| February 14, 2024 | 134.28M |
| February 13, 2024 | 119.37M |
| February 12, 2024 | 143.40M |
| February 09, 2024 | 102.32M |
| February 08, 2024 | 97.97M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
52.69M
Minimum
Nov 10 2023
2.571B
Maximum
Dec 23 2020
945.94M
Average
944.89M
Median
Dec 30 2019
Market Cap Benchmarks
| AIM ImmunoTech Inc | 23.20M |
| Perspective Therapeutics Inc | 880.37M |
| Protalix BioTherapeutics Inc | 84.01M |
| Electromed Inc | 124.78M |
| Armata Pharmaceuticals Inc | 96.33M |
Market Cap Related Metrics
| PS Ratio | 0.5067 |
| PEG Ratio | -0.0198 |
| Price to Book Value | 1.104 |
| Price | 0.5115 |
| Earnings Yield | -287.4% |
| PEGY Ratio | -0.0198 |